Inhibition of DRP1 and NRF2 restored cisplatin sensitivity and stopped the spread of cancer cells in a mouse model of metastatic breast cancer cells latent in the lung soft tissue [70]. This evidence concerns the gene DNM1L and breast carcinoma.